BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Allergy and Asthma Excellence Network - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Allergy and Asthma Excellence Network
X-ORIGINAL-URL:https://sandbox.global-allergy.network
X-WR-CALDESC:Events for Global Allergy and Asthma Excellence Network
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240202
DTEND;VALUE=DATE:20240203
DTSTAMP:20260405T192615
CREATED:20240105T113727Z
LAST-MODIFIED:20241014T094944Z
UID:5440-1706832000-1706918399@sandbox.global-allergy.network
SUMMARY:ACARE levelUp Preceptorship Abu Dhabi
DESCRIPTION:ACARE levelUp Preceptorship Abu Dhabi\nTopics highlights: \n\nConsensus on diagnosis and management of Hereditary Angioedema in the Middle East\nMast cell and Bradykinin Mediated Angioedema\nClinical Case discussions on identifying HAE and LTP treatment\nThe Future of HAE Management\n\n  \nInternational Faculty: \nMarcus Maurer\nMarcus Magerl\nThomas Buttgereit \n  \nGulf Faculty: \nMohamed Abuzakouk\nIman Nasr\nRand Arnaout\nFulvio Salvo \n  \n 
URL:https://sandbox.global-allergy.network/event/acare-levelup-preceptorship-abu-dhabi/
CATEGORIES:Preceptorship
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20240220T170000
DTEND;TZID=Europe/Berlin:20240220T180000
DTSTAMP:20260405T192615
CREATED:20231214T140413Z
LAST-MODIFIED:20241017T085545Z
UID:1737-1708448400-1708452000@sandbox.global-allergy.network
SUMMARY:MODERN LONG-TERM PROPHYLAXIS AND TREATMENT OPTIMIZATION BASED ON REAL WORLD EXPERIENCE
DESCRIPTION:Register here for our 10th ACARE Make a Difference (MAD) Webinar! \nMODERN LONG-TERM PROPHYLAXIS AND TREATMENT OPTIMIZATION BASED ON REAL WORLD EXPERIENCE \nDate: 20 February 2024 \nTime: 17:00 to 18:00 CET \n\n\n\n\nACARE Make A Difference is an eleven-part webinar series with a primary focus on the diagnostic evaluation of patients experiencing recurrent angioedema\, including those with hereditary angioedema (HAE)\, as well as the enhancement of therapy control and optimization. \nThe overarching goal of this webinar series is to facilitate the provision of optimal therapy to all individuals afflicted with recurrent angioedema\, particularly those affected by HAE\, at the earliest possible stage. \nThroughout these webinars\, various topics will be explored\, including strategies to expedite the diagnosis process and reduce instances of misdiagnosis\, methods for family screening in HAE patients\, the implementation of closely monitored therapy control measures\, and guidance on the continual refinement of therapeutic approaches. This specific webinar will place special emphasis on long- term prophylaxis and treatment optimization based on real world experience. \n\n\n\n\nTOPICS and SPEAKERS \n\nIntroduction – Prof. Dr. Marcus Maurer\, Germany\nC1-Inhibitor and Long-Term Prophylaxis in real life – Dr. Stefan Cimbollek\, Spain\nLanadelumab and Long-Term Prophylaxis adaption – Dr. Mauro Cancian\, Italy\nOral treatments advantages/disadvantages compared to Long-Term Prophylaxis –Dr. Emel Aygören Pursun\, Germany\nQ&A – All faculty\n\nAll speakers from: \n\nCharité – Universitätsmedizin Berlin Institute of Allergology IFA & Fraunhofer ITMP Immunology and Allergology IA\,\n\n\n\n\n\n\nFacultativo Especialista de Área en Hospital Universitario Virgen del Rocío\, Sevilla\, Spain\,\n\n\n\n\n\n\nBarts Health NHS Trust\, London\, United Kingdom\,\n\n\n\n\n\n\nKlinik für Kinder- und Jugendmedizin\, Universitätsklinikum Frankfurt\, Frankfurt\, Germany\n\n  \n\n\n\n\n\n\n\n\n\n\n\n\nMake a Difference is initiated by ACARE and funded by Takeda Pharmaceutical Company Limited. \nRegister now for the MAD 10 webinar
URL:https://sandbox.global-allergy.network/event/modern-long-term-prophylaxis-and-treatment-optimization-based-on-real-world-experience/
CATEGORIES:ACARE Make a Difference
END:VEVENT
END:VCALENDAR